Q32 Bio Correlations
| QTTB Stock | 3.88 0.02 0.51% |
The current 90-days correlation between Q32 Bio and NextCure is -0.04 (i.e., Good diversification). The correlation of Q32 Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Q32 Bio Correlation With Market
Very poor diversification
The correlation between Q32 Bio and DJI is 0.82 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Q32 Bio and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Q32 Stock
| 0.7 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.65 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.64 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.77 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.62 | VERA | Vera Therapeutics Sell-off Trend | PairCorr |
| 0.64 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.81 | DRTS | Alpha Tau Medical | PairCorr |
| 0.78 | DSGN | Design Therapeutics | PairCorr |
| 0.68 | SAB | Sonic Healthcare Earnings Call This Week | PairCorr |
| 0.89 | 0P6S | Bayer AG NA | PairCorr |
| 0.75 | DVAX | Dynavax Technologies Earnings Call This Week | PairCorr |
Moving against Q32 Stock
| 0.76 | OSE | OSE Pharma SA | PairCorr |
| 0.65 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.58 | VCEL | Vericel Corp Ord | PairCorr |
| 0.56 | DRMA | Dermata Therapeutics | PairCorr |
| 0.45 | ABNX | Abionyx Pharma SA | PairCorr |
| 0.38 | VCYT | Veracyte | PairCorr |
| 0.34 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.78 | DTIL | Precision BioSciences | PairCorr |
| 0.78 | IGS1 | India Globalization | PairCorr |
| 0.74 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.71 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.67 | VKTX | Viking Therapeutics | PairCorr |
| 0.67 | CDTTW | Conduit Pharmaceuticals | PairCorr |
| 0.65 | VSTM | Verastem | PairCorr |
| 0.57 | XE9 | Xencor Inc | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Q32 Stock performing well and Q32 Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Q32 Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NXTC | 4.12 | 0.79 | 0.18 | 1.68 | 3.68 | 9.04 | 43.11 | |||
| BOLD | 2.12 | (0.10) | 0.00 | (0.17) | 0.00 | 4.24 | 16.75 | |||
| SABS | 2.93 | 0.36 | 0.07 | (1.26) | 3.48 | 6.13 | 22.52 | |||
| ANTX | 2.49 | (0.13) | 0.00 | (0.16) | 0.00 | 4.55 | 32.31 | |||
| VRCA | 5.39 | 0.76 | 0.14 | 0.39 | 5.23 | 13.76 | 52.65 | |||
| PSTV | 4.97 | (0.93) | 0.00 | (0.28) | 0.00 | 9.43 | 48.30 | |||
| GBIO | 1.60 | 0.09 | 0.00 | (0.12) | 2.17 | 3.39 | 14.01 | |||
| INTS | 4.88 | (0.60) | 0.00 | (0.22) | 0.00 | 11.43 | 51.11 | |||
| ITRM | 4.71 | (1.11) | 0.00 | (0.37) | 0.00 | 9.38 | 26.92 | |||
| SONN | 10.16 | (0.29) | 0.00 | (0.30) | 0.00 | 19.48 | 69.59 |
Q32 Bio Corporate Management
| Saul Fink | Chief Officer | Profile | |
| Kathryn MBA | Manufacturing Chemistry | Profile | |
| Adrien Sipos | Interim Officer | Profile | |
| Lee MBA | Chief Officer | Profile | |
| Maria MPH | Executive Operations | Profile |